On Friday, Humacyte Inc (NASDAQ: HUMA) opened higher 17.32% from the last session, before settling in for the closing price of $1.79. Price fluctuations for HUMA have ranged from $1.15 to $6.77 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 42.43%. Company’s average yearly earnings per share was noted 70.20% at the time writing. With a float of $131.52 million, this company’s outstanding shares have now reached $156.34 million.
Humacyte Inc (HUMA) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Humacyte Inc is 17.20%, while institutional ownership is 36.14%. The most recent insider transaction that took place on Aug 19 ’25, was worth 1,793,000. In this transaction Director of this company sold 1,100,000 shares at a rate of $1.63, taking the stock ownership to the 591,685 shares. Before that another transaction happened on Aug 18 ’25, when Company’s Director sold 549,360 for $1.83, making the entire transaction worth $1,005,329. This insider now owns 1,691,685 shares in total.
Humacyte Inc (HUMA) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.26 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at -0.25) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 70.20% per share during the next fiscal year.
Humacyte Inc (NASDAQ: HUMA) Trading Performance Indicators
Check out the current performance indicators for Humacyte Inc (HUMA). In the past quarter, the stock posted a quick ratio of 1.93. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 406.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.46, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.35 in one year’s time.
Technical Analysis of Humacyte Inc (HUMA)
The latest stats from [Humacyte Inc, HUMA] show that its last 5-days average volume of 3.5 million was inferior to 3.93 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 63.33%.
During the past 100 days, Humacyte Inc’s (HUMA) raw stochastic average was set at 46.45%, which indicates a significant decrease from 84.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.15 in the past 14 days, which was lower than the 0.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.80, while its 200-day Moving Average is $2.63. Now, the first resistance to watch is $2.28. This is followed by the second major resistance level at $2.47. The third major resistance level sits at $2.71. If the price goes on to break the first support level at $1.85, it is likely to go to the next support level at $1.61. Assuming the price breaks the second support level, the third support level stands at $1.42.
Humacyte Inc (NASDAQ: HUMA) Key Stats
There are currently 158,372K shares outstanding in the company with a market cap of 333.55 million. Presently, the company’s annual sales total 0 K according to its annual income of -148,700 K. Last quarter, the company’s sales amounted to 300 K and its income totaled -37,660 K.
